It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Protagonist Therapeutics Inc (PTGX) shows that investor sentiment remained same, with the stock’s consolidated last price to $14.54. The Protagonist Therapeutics Inc has recorded 11,368 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Protagonist Therapeutics Announces Appointment of Daniel Swisher to Its Board of Directors.
Protagonist Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $14.54 and fluctuated between $14.57 as its day high and $13.76 as its day low. The current market capitalization of Protagonist Therapeutics Inc is $836.49M. A total of 0.94 million shares were traded on the day, compared to an average of 645.09K shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, PTGX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 13 BUYs and 5 SELLs from insiders. Insiders purchased 216,300 shares during that period but sold 31,654.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for PTGX in the last 3 months, the mean price target is $38.17 with high estimates of $49.00 and low estimates of $32.00. In terms of 52-week highs and lows, PTGX has a high of $30.10 and a low of $7.24.
As of this writing, PTGX has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.67 per share and a lower estimate of -$0.76. The company reported an EPS of -$0.67 in the last quarter, which was 8.20% higher than expectations of -$0.73.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PTGX’s latest balance sheet shows that the firm has $326.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.86M in debt and $44.02M in liabilities at the time. Its Book Value Per Share was $5.11, while its Total Shareholder’s Equity was $300.02M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTGX is Buy with a score of 5.00.